BlackRock Health Sciences Term Trust (BMEZ)
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $895.6M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $895.6M
- Dividend yield
- 8.62%
- Shares outstanding
- 58.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
BlackRock Health Sciences Term Trust (BMEZ) Stock Price
- Trading near its 52-week high.
- Pays a dividend yielding about 8.62% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BlackRock Health Sciences Term Trust.
Write a review
News about BlackRock Health Sciences Term Trust
News & sentiment via Polygon.io
BlackRock Health Sciences Term Trust: frequently asked questions
Is BlackRock Health Sciences Term Trust an American company?
BlackRock Health Sciences Term Trust is a US-based company headquartered in Wilmington, Delaware, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BlackRock Health Sciences Term Trust headquartered?
BlackRock Health Sciences Term Trust is headquartered in Wilmington, Delaware, United States.
Is BlackRock Health Sciences Term Trust publicly traded?
Yes — BlackRock Health Sciences Term Trust is a publicly traded company. Its stock trades under the ticker symbol BMEZ on the NYSE.
